Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed

By Yoshida Kanako   Hai Hoang   Tamori Akihiro   Teranishi Yuga   Kozuka Ritsuzo   Motoyama Hiroyuki   Kawamura Etsushi   Hagihara Atsushi   Uchida-Kobayashi Sawako   Morikawa Hiroyasu   Enomoto Masaru   Murakami Yoshiki   Kawada Norifumi  

International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-05 ,pp. : 962-962

MDPI

Access to resources Recommend Favorite

Hepatitis C Virus and Natural Compounds: A New Antiviral Approach?

By Calland Noémie   Dubuisson Jean   Rouillé Yves   Séron Karin  

Viruses, Vol. 4, Iss. 10, 2012-10 ,pp. : 2197-2217

MDPI

Access to resources Recommend Favorite

CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies

By Zona Laetitia   Tawar Rajiv G.   Zeisel Mirjam B.   Schuster Catherine   Lupberger Joachim   Baumert Thomas F.  

Viruses, Vol. 6, Iss. 2, 2014-02 ,pp. : 875-892

MDPI

Access to resources Recommend Favorite

The Hepatitis C Virus Nonstructural Protein 2 (NS2): An Up-and-Coming Antiviral Drug Target

By Lorenz Ivo C.  

Viruses, Vol. 2, Iss. 8, 2010-08 ,pp. : 1635-1646

MDPI

Access to resources Recommend Favorite

Innate Antiviral Immune Responses to Hepatitis B Virus

By Ait-goughoulte Malika   Lucifora Julie   Zoulim Fabien   Durantel David  

Viruses, Vol. 2, Iss. 7, 2010-07 ,pp. : 1394-1410

MDPI

Access to resources Recommend Favorite